NextRNA Therapeutics

Cambridge, United States

NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.

$46.8M raised

Mar 2022

Series A

Biotechnology Health Care Therapeutics

Top Investors

Willett Advisors LLC Jefferies Rivas Capital Lightchain Capital Evans Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NextRNA Therapeutics

How much funding has NextRNA Therapeutics raised?

NextRNA Therapeutics has raised $46.8M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are NextRNA Therapeutics's investors?

NextRNA Therapeutics's investors include Willett Advisors LLC, Jefferies, Rivas Capital, Lightchain Capital, Evans Capital.

Where is NextRNA Therapeutics headquartered?

NextRNA Therapeutics is headquartered in Cambridge, United States.

What does NextRNA Therapeutics do?

NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.

What stage is NextRNA Therapeutics at?

NextRNA Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2022.

MLA

"NextRNA Therapeutics — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/nextrna-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2022). NextRNA Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/nextrna-therapeutics

Wikipedia (cite web)

{{cite web |title=NextRNA Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nextrna-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K